Comparative vaccine-specific and other injectable-specific risks of injection-site sarcomas in cats.

Journal of the American Veterinary Medical Association

Volumn 241, Issue 5, 2012, Pages 595-602

  Srivastav, Anup ^a   Kass, Philip H ^b   McGill, Lawrence D ^b   Farver, Thomas B ^b   Kent, Michael S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INACTIVATED VACCINE; RECOMBINANT VACCINE; VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BASAL CELL CARCINOMA; CASE CONTROL STUDY; CAT; CAT DISEASE; COMPARATIVE STUDY; FEMALE; INJECTION; MALE; PREVALENCE; PROSPECTIVE STUDY; SARCOMA; VACCINATION;

ADRENAL CORTEX HORMONES; ANIMALS; CASE-CONTROL STUDIES; CAT DISEASES; CATS; FEMALE; INJECTIONS; MALE; NEOPLASMS, BASAL CELL; PREVALENCE; PROSPECTIVE STUDIES; SARCOMA; VACCINATION; VACCINES; VACCINES, INACTIVATED; VACCINES, SYNTHETIC;

MLCS; MLOWN;

EID: 84871857407     PISSN: None     EISSN: 1943569X     Source Type: Journal    
DOI: 10.2460/javma.241.5.595     Document Type: Article

References (0)